Gregg Wallis

407 total citations
14 papers, 285 citations indexed

About

Gregg Wallis is a scholar working on Molecular Biology, Hematology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Gregg Wallis has authored 14 papers receiving a total of 285 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Hematology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Gregg Wallis's work include Glycosylation and Glycoproteins Research (4 papers), Microbial Metabolites in Food Biotechnology (3 papers) and Multiple Myeloma Research and Treatments (3 papers). Gregg Wallis is often cited by papers focused on Glycosylation and Glycoproteins Research (4 papers), Microbial Metabolites in Food Biotechnology (3 papers) and Multiple Myeloma Research and Treatments (3 papers). Gregg Wallis collaborates with scholars based in United Kingdom, Netherlands and Belgium. Gregg Wallis's co-authors include F. W. Hemming, John F. Peberdy, Mark T. Drayson, A.R. Bradwell, Stephen J. Harding, Graham P. Mead, Hugh D Carr-Smith, Richard L. Easton, Stephen Harding and Ursula Rinas and has published in prestigious journals such as SHILAP Revista de lepidopterología, Analytical Biochemistry and International Journal of Molecular Sciences.

In The Last Decade

Gregg Wallis

13 papers receiving 276 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gregg Wallis United Kingdom 8 175 77 77 57 36 14 285
Richard Bernasconi France 7 283 1.6× 65 0.8× 50 0.6× 29 0.5× 44 1.2× 9 428
Shannon L. Ward United Kingdom 8 290 1.7× 27 0.4× 63 0.8× 63 1.1× 60 1.7× 17 505
Susumu Iwasa Japan 12 145 0.8× 34 0.4× 36 0.5× 109 1.9× 22 0.6× 31 396
Norman Barnabé Canada 11 230 1.3× 23 0.3× 12 0.2× 28 0.5× 36 1.0× 15 346
Maria Dan United States 10 121 0.7× 50 0.6× 20 0.3× 14 0.2× 27 0.8× 22 319
Leslie L. Lenny United States 9 136 0.8× 133 1.7× 53 0.7× 6 0.1× 33 0.9× 13 381
Sandra Westphal United States 7 90 0.5× 66 0.9× 82 1.1× 17 0.3× 8 0.2× 10 398
Faye Fang United States 5 244 1.4× 23 0.3× 43 0.6× 16 0.3× 32 0.9× 7 406
Kasemsiri Chandarajoti Thailand 8 257 1.5× 54 0.7× 16 0.2× 8 0.1× 148 4.1× 17 431
Toshimasa Nakayama Japan 9 143 0.8× 13 0.2× 40 0.5× 19 0.3× 40 1.1× 22 367

Countries citing papers authored by Gregg Wallis

Since Specialization
Citations

This map shows the geographic impact of Gregg Wallis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregg Wallis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregg Wallis more than expected).

Fields of papers citing papers by Gregg Wallis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregg Wallis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregg Wallis. The network helps show where Gregg Wallis may publish in the future.

Co-authorship network of co-authors of Gregg Wallis

This figure shows the co-authorship network connecting the top 25 collaborators of Gregg Wallis. A scholar is included among the top collaborators of Gregg Wallis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregg Wallis. Gregg Wallis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Barnidge, David R., et al.. (2024). Endogenous monoclonal immunoglobulins analyzed using the EXENT® solution and LC-MS. SHILAP Revista de lepidopterología. 32. 31–40. 6 indexed citations
2.
Sadée, Christoph, Stephen Harding, Gregg Wallis, et al.. (2022). Determination of IgG1 and IgG3 SARS-CoV-2 Spike Protein and Nucleocapsid Binding—Who Is Binding Who and Why?. International Journal of Molecular Sciences. 23(11). 6050–6050. 7 indexed citations
3.
Berlanga, Oscar, Simon J. North, David R. Barnidge, et al.. (2019). QIP-MS: An alternative to electrophoresis to distinguish endogenous M-proteins from therapeutic monoclonal antibodies in multiple myeloma. Clinical Lymphoma Myeloma & Leukemia. 19(10). e143–e144.
4.
Stordeur, Patrick, Stephen Jolles, Mark Ponsford, et al.. (2018). Quantification of human complement C2 protein using an automated turbidimetric immunoassay. Clinical Chemistry and Laboratory Medicine (CCLM). 56(9). 1498–1506. 9 indexed citations
5.
Parker, Antony R., Juan Irure‐Ventura, Ricardo Gómez de la Torre, et al.. (2017). Measurement of the IgG2 response to Pneumococcal capsular polysaccharides may identify an antibody deficiency in individuals referred for immunological investigation. Journal of Immunoassay and Immunochemistry. 38(5). 514–522. 4 indexed citations
6.
Parker, Antony R., et al.. (2016). Purification and characterisation of anti-pneumococcal capsular polysaccharide IgG immunoglobulins. Clinical Biochemistry. 50(1-2). 80–83. 1 indexed citations
7.
Young, Elizabeth A., et al.. (2014). Estimation of polyclonal IgG4 hybrids in normal human serum. Immunology. 142(3). 406–413. 22 indexed citations
8.
Bradwell, A.R., Stephen J. Harding, Gregg Wallis, et al.. (2009). Assessment of Monoclonal Gammopathies by Nephelometric Measurement of Individual Immunoglobulin κ/λ Ratios. Clinical Chemistry. 55(9). 1646–1655. 85 indexed citations
9.
Wallis, Gregg, F. W. Hemming, & John F. Peberdy. (2001). β-Galactofuranoside glycoconjugates on conidia and conidiophores ofAspergillus niger. FEMS Microbiology Letters. 201(1). 21–27. 11 indexed citations
10.
Wallis, Gregg, Robert J. Atterbury, Ursula Rinas, et al.. (2001). The effect of pH on glucoamylase production, glycosylation and chemostat evolution of Aspergillus niger. Biochimica et Biophysica Acta (BBA) - General Subjects. 1527(3). 112–122. 15 indexed citations
11.
Wallis, Gregg, F. W. Hemming, & John F. Peberdy. (2001). An extracellular β-galactofuranosidase from Aspergillus niger and its use as a tool for glycoconjugate analysis. Biochimica et Biophysica Acta (BBA) - General Subjects. 1525(1-2). 19–28. 28 indexed citations
12.
Wiebe, Marilyn G., Geoff Robson, Anthony P. J. Trinci, et al.. (2001). Production of tissue plasminogen activator (t‐PA) in Aspergillus niger. Biotechnology and Bioengineering. 76(2). 164–174. 51 indexed citations
13.
Wallis, Gregg, et al.. (2001). Galactofuranoic‐oligomannose N‐linked glycans of α‐galactosidase A fromAspergillus niger. European Journal of Biochemistry. 268(15). 4134–4143. 40 indexed citations
14.
Hemming, F. W., Gregg Wallis, & John F. Peberdy. (2000). An Unambiguous Microassay of Galactofuranose Residues in Glycoconjugates Using Mild Methanolysis and High pH Anion-Exchange Chromatography. Analytical Biochemistry. 279(2). 136–141. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026